Elsevier

Cellular Immunology

Volume 205, Issue 2, 1 November 2000, Pages 84-93
Cellular Immunology

Regular Article
Expression of Delta Opioid Receptors by Splenocytes from SEB-Treated Mice and Effects on Phosphorylation of MAP Kinase

https://doi.org/10.1006/cimm.2000.1717Get rights and content

Abstract

Delta opioid receptors (DORs) are known to modulate multiple T-cell responses. However, little is known about the expression of these receptors. These studies evaluated the expression of DOR mRNA and protein after a single in vivo exposure to staphylococcal enterotoxin B (SEB). SEB (20 μg, ip) significantly enhanced splenocyte DOR mRNA expression 8 and 24 h after injection. SEB also increased the fractions of the total splenocyte (5 to 20%) and T-cell (8 to 50%) populations expressing DOR protein. In saline-treated animals, DOR relative fluorescence intensity per cell was 11.1 ± 0.62 units (mean ± SEM), increasing to 16.1 ± 1.7 after exposure to SEB. DOR fluorescence intensity significantly increased to 33.5 ± 2.0 units in a subpopulation of T-cells. Thus, SEB significantly increased DOR expression in vivo, affecting both mRNA and protein levels primarily within the T-cell population. To determine whether T-cell DORs modulate the activity of extracellular-regulated kinases (ERKs), the phosphorylation of ERKs 1 and 2 was studied using splenocytes from SEB-treated mice. At concentrations from 10−8 to 10−6 M, [d-Ala2-d-Leu5]-enkephalin, a selective DOR agonist, significantly inhibited anti-CD3-ϵ-induced phosphorylation of the ERKs. Therefore, the DORs expressed by activated T-cells are capable of attenuating T-cell activation that depends on ERK phosphorylation.

References (41)

  • L.C. Cantley et al.

    Oncogenes and signal transduction

    Cell

    (1991)
  • F. Lopez et al.

    The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling

    J. Biol. Chem.

    (1997)
  • N.E. Sibinga et al.

    Opioid peptides and opioid receptor in cells of the immune system

    Annu. Rev. Immunol.

    (1988)
  • D.J. Carr

    The role of endogenous opioids and their receptors in the immune system

    Proc. Soc. Exp. Biol. Med.

    (1991)
  • K.M. Linner et al.

    Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation

    J. Immunol.

    (1995)
  • N.A. Shahabi et al.

    Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells

    J. Pharmacol. Exp. Ther.

    (1995)
  • N.A. Shahabi et al.

    β-Endorphin enhances Concanavalin-A-stimulated calcium mobilization by murine splenic T cells

    Endocrinology

    (1996)
  • C.J. Evans et al.

    Cloning of a delta opioid receptor by functional expression

    Science

    (1992)
  • B. Miller

    Delta opioid receptor expression is induced by concanavalin A in CD4+ T cells

    J. Immunol.

    (1996)
  • M.D. Li et al.

    Regulation of delta opioid receptor expression by anti-CD3-ϵ, PMA, and ionomycin in murine splenocytes and T cells

    J. Leukocyte Biol.

    (1999)
  • Cited by (25)

    • Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth

      2012, Journal of Biological Chemistry
      Citation Excerpt :

      In the central nervous system, β-endorphin and enkephalins are known to bind to classical DOR and MOR (7). Opioid receptors have been shown to be present in splenic cells (8), including NK cells (9). Acute treatments of opioid receptor agonists have been shown to stimulate NK cell cytolytic activity, and an opioid receptor antagonist blocks β-endorphin-stimulated NK cell function in the spleen (3).

    • Immune conditions associated with CD4 <sup>+</sup> T effector-induced opioid release and analgesia

      2012, Pain
      Citation Excerpt :

      The preferential contribution of peripheral DOR in controlling mechanical hyperalgesia [9,10,27] raises the question of whether antigen-experienced T cells may alleviate thermal hyperalgesia with the same efficiency. The release of high amounts of enkephalins by effector CD4+ T lymphocytes within the site of inflammation coincides with an increased expression of opioid receptors including DOR in primary sensory fibers [10,23,34], as well as in immune cells such as DCs and CD4+ T lymphocytes [2,3,16,28]. DOR is upregulated on TCR-induced activation of naïve CD4+ T lymphocytes by cognate antigen-experienced dendritic cells within draining lymph nodes [14].

    View all citing articles on Scopus

    This work was supported by NIDA DA-04196.

    View full text